Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical, Inc.

Intuitive develops, manufactures, and markets robotic-assisted surgical systems, particularly the da Vinci Surgical System, for minimally invasive surgery.

Intuitive

Intuitive Fosun Hong Kong

Intuitive Israel

Intuitive Fosun

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.

Our three-webinar series, Expert Perspectives in Thoracic Oncology, continues with our second episode: Aligning Stakeholders with Data to Improve Patient Pathways.

In this conversation, Dr. Pepper and Moses Cone Thoracic Oncology Team will discuss the importance of engaging with a variety of multidisciplinary colleagues as you build your thoracic oncology program.

July 11th, 2000, isn’t where our story began, but it was a landmark day in our mission to transform surgery—the day that the first da Vinci Surgical System received FDA clearance. 
 
In the years since, surgeons around the world have used five generations of da Vinci systems to help millions of patients. Each generation was an evolution of technology on a journey of progress that never truly ends.
 
Transforming surgery for the benefit of patients, surgeons, and hospitals—that’s Intuitive.

Six years ago, when Intuitive’s Women in da Vinci Surgery Symposium began, there were just six female surgeons in the room. This year? Over 200 surgeons, pulmonologists, and hospital executives gathered in Atlanta, Georgia, to connect, learn, and grow together.

Explore key takeaways from this year’s symposium.

“The best way to grow our people is to grow our business,” says Anuj Mittal, CFO of Intuitive India. Over the past few years, our business has experienced incredible growth, but there's still a massive untapped opportunity in India. We’re looking for talented individuals ready to seize this moment.

At Intuitive India, we’re not just transforming healthcare; we’re building transformative careers. Our vision of enhancing minimally invasive care drives us to innovate, challenge ourselves, and lead in our industry.

Curious to learn more? We sat down with Anuj and fellow leaders Amit Garg and Keith Lavery to discuss the vast opportunities for new team members and the collaborative culture that fuels our growth. Discover insights about our new Global Capability Center and how we’re just scratching the surface of what’s possible.

Ready to be part of something bigger? Read the full story on our blog and see how you can make a real impact with us.
https://lnkd.in/e8RmZn_a
 
#WeAreIntuitive

When Dr. Laila Rashidi was asked how she communicates the benefits of robotic surgery to her patients and colleagues, she said, "Whenever I meet referring physicians or talk to my patients, I always have data to support why I'm doing what I'm doing."

In our new Surgeon Spotlight series, we'll be exploring the world of surgery through the eyes of some of the most skilled and knowledgable physicians in the world. Up first, the inimitable Dr. Laila Rashidi, medical director for colon and rectal surgery at MultiCare Health System.

“The marriage of Case Insights and the ability to review my operative videos—we’re finally at a point where I can put data to the words I’ve been trying to articulate with my fellows for a decade.”
-Mark Soliman, Medical Director of Colorectal Surgery for AdventHealth.

Explore how Case Insights enables surgeons to understand surgical performance like never before.

https://lnkd.in/eEinD5MG

	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	2.27B -	2.13B 5.89%	2.38B 11.85%	2.70B 13.42%	3.13B 15.70%	3.72B 19.03%	4.48B 20.25%	4.36B 2.68%	5.71B 31.01%	6.22B 8.97%	7.12B 14.49%
cost of revenue	670.90M -	717.90M 7.01%	806.50M 12.34%	814.30M 0.97%	934.80M 14.80%	1.12B 19.82%	1.37B 22.16%	1.50B 9.42%	1.75B 16.99%	2.03B 15.68%	2.39B 18.18%
gross profit	1.59B -	1.41B 11.32%	1.58B 11.61%	1.89B 19.79%	2.19B 16.08%	2.60B 18.69%	3.11B 19.43%	2.86B 8.01%	3.96B 38.35%	4.20B 6.00%	4.73B 12.71%
selling and marketing expenses
general and administrative expenses	574M -	691M 20.38%	640.50M 7.31%	705.30M 10.12%	810.90M 14.97%	986.60M 21.67%
selling general and administrative expenses	574M -	691M 20.38%	640.50M 7.31%	705.30M 10.12%	810.90M 14.97%	986.60M 21.67%	1.18B 19.44%	1.22B 3.22%	1.47B 20.57%	1.74B 18.64%	1.96B 12.87%
research and development expenses	167.70M -	178M 6.14%	197.40M 10.90%	239.60M 21.38%	328.60M 37.15%	418.10M 27.24%	557.30M 33.29%	595.10M 6.78%	671M 12.75%	879M 31.00%	998.80M 13.63%
other expenses
cost and expenses	741.70M -	1.59B 113.95%	1.64B 3.62%	1.76B 6.98%	2.07B 17.91%	2.52B 21.72%	3.10B 22.94%	3.31B 6.59%	3.89B 17.55%	4.65B 19.44%	5.36B 15.33%
operating expenses	741.70M -	869M 17.16%	837.90M 3.58%	944.90M 12.77%	1.14B 20.59%	1.40B 23.27%	1.74B 23.56%	1.81B 4.36%	2.14B 18.00%	2.62B 22.52%	2.96B 13.13%
interest expense										29.70M -
ebitda	852.50M -	544.80M 36.09%	740M 35.83%	945.20M 27.73%	1.05B 11.57%	1.20B 13.73%	1.37B 14.60%	1.05B 23.62%	1.82B 73.46%	1.58B 13.39%	2.19B 38.77%
operating income	852.50M -	544.80M 36.09%	740M 35.83%	945.20M 27.73%	1.05B 11.57%	1.20B 13.73%	1.37B 14.60%	773.60M 43.72%	1.82B 135.39%	1.21B 33.48%	1.77B 45.86%
depreciation and amortization	67.30M -	74.40M 10.55%	89.50M 20.30%	92.10M 2.91%	99.10M 7.60%	122.80M 23.92%	203M 65.31%	276.20M 36.06%	310.20M 12.31%	365.80M 17.92%	421.80M 15.31%
total other income expenses net	18.40M -	4.20M 77.17%	18.50M 340.48%	35.60M 92.43%	41.90M 17.70%	80.10M 91.17%	127.70M 59.43%	433.40M 239.39%	69.30M 84.01%	395.50M 470.71%	192.10M 51.43%
income before tax	870.90M -	549M 36.96%	758.50M 38.16%	980.80M 29.31%	1.10B 11.80%	1.28B 16.69%	1.50B 17.41%	1.21B 19.65%	1.89B 56.61%	1.61B 15.00%	1.96B 21.91%
income tax expense	199.90M -	130.20M 34.87%	169.70M 30.34%	244.90M 44.31%	436.50M 78.24%	154.50M 64.60%	120.40M 22.07%	140.20M 16.45%	162.20M 15.69%	262.40M 61.78%	141.60M 46.04%
net income	671M -	418.80M 37.59%	588.80M 40.59%	735.90M 24.98%	660M 10.31%	1.13B 70.89%	1.38B 22.29%	1.06B 23.11%	1.70B 60.72%	1.32B 22.43%	1.80B 35.98%
weighted average shs out	360.97M -	332.10M 8.00%	333.90M 0.54%	344.70M 3.23%	335.10M 2.79%	341.10M 1.79%	346.20M 1.50%	351M 1.39%	356.10M 1.45%	356.80M 0.20%	351.20M 1.57%
weighted average shs out dil	360.97M -	339.30M 6.00%	341.10M 0.53%	353.70M 3.69%	348.90M 1.36%	356.40M 2.15%	358.50M 0.59%	360.90M 0.67%	365.80M 1.36%	366.80M 0.27%	357.40M 2.56%
eps	1.86 -	1.26 32.26%	1.76 39.68%	2.13 21.02%	1.97 7.51%	3.31 68.02%	3.98 20.24%	3.02 24.12%	4.79 58.61%	3.71 22.55%	5.12 38.01%
epsdiluted	1.86 -	1.23 33.87%	1.73 40.65%	2.08 20.23%	1.89 9.13%	3.16 67.20%	3.85 21.84%	2.94 23.64%	4.66 58.50%	3.60 22.75%	5.03 39.72%

COM:INTUITIVE

Intuitive

Last Close

541.82

21/11 21:00

Market Cap

157.75B

Beta: -

Volume Today

1.39M

Avg: -

Preview